Emory’s Bone Marrow and Stem Cell Transplant Center in Atlanta is celebrating its 5,000th patient receiving a bone marrow or stem cell transplant this summer. As we commemorate this milestone, we renew our commitment to offering your patients the most innovative treatments and care by our experienced, compassionate clinical team.
Our plans for continuing advances:
We continue to grow.
Since our first autologous and allogeneic transplants in 1979, we have become one of the ten largest programs in the U.S., with 431 transplants last year. With the expansion of Emory University Hospital next year, our patient bed capacity will double, providing more access for your patients.
We are expanding the types of patient served.
Well known as a referral center for lymphoma and myeloma patients, we are increasing the number of leukemia patients transplanted. We also have active programs for allogeneic transplants for patients with severe sickle cell disease and autologous transplants for patients with relapsed germ cell cancer. We are one of a handful of centers able to perform “bloodless†transplants.
We are providing patients more clinical trials, such as immunotherapy.
Because Winship Cancer Institute is Georgia’s only National Cancer Institute-designated center, we offer transplant patients access to more than 200 clinical trials. Winship is also a core site in Georgia for the prestigious Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
We are proud to work with you and other physicians across the region to bring the leading transplant care to your patients. Thank you for your partnership in the care of patients and your confidence in our program.
Watch Tamara’s patient success story at advancingyourhealth.org/Winship
Should you have questions or wish to discuss the care of your patients, please call 404-778-1900.
